Chimeric Artificial Interference RNA (aiRNA) for RNAi-based cancer therapy

by | Dec 16, 2019 | Wang, Xiaowei

— Technology Description

In search of more effective cancer treatments, inventors in Dr. Xiaowei Wang’s lab at Washington University School of Medicine have developed artificial interference RNA (aiRNA). aiRNA is a patented chimeric RNAi that combines the multi-target abilities of miRNAs and t…

A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma

by | Mar 10, 2018 | Wang, Xiaowei

— Oropharyngeal squamous cell carcinoma (OSCC) rates have increased significantly in recent years, and because of the different underlying causes of the disease no single treatment regime seems to be advantageous over another. Currently, the prognosis of OSCC is based on clinical features of the OSCC…

Your Collections

Name	# Summaries	Author
Cardiovascular	15	peek
COVID-19	13	peek
Immuno-Oncology	15	peek
Oncology	26	peek
PET Tracers	14	peek
Radiology	14	peek

Create a Collection

Creating...

WASHU INNOVATION CATALOG

Chimeric Artificial Interference RNA (aiRNA) for RNAi-based cancer therapy

A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma

Your Collections

Office of Technology Management